RobertLRednerMD
Hematology • Pittsburgh, PAProfessor, Medicine, University of Pittsburgh School of Medicine
Dr. Redner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5115 Centre Avenue
Upmc Cancer Pavillion
Pittsburgh, PA 15232Phone+1 412-692-4724- Is this information wrong?
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1983 - 1984
Johns Hopkins UniversityResidency, Internal Medicine, 1980 - 1983
Harvard Medical SchoolClass of 1980
Certifications & Licensure
CA State Medical License 1983 - Present
PA State Medical License 1991 - 2024
MD State Medical License 1984 - 1993- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid Leukemia Start of enrollment: 2008 Sep 01
- A Randomized Clinical Trial of Lenalidomide (CC-5013) and Dexamethasone With and Without Autologous Peripheral Blood Stem Cell Transplant in Patients With Newly Diagnosed Multiple Myeloma Start of enrollment: 2008 Jan 01
- Study of Dasatinib and All-Trans Retinoic Acid for Relapsed/Refractory and/or Elderly Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome Start of enrollment: 2011 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial.Vu H Duong, Amy S Ruppert, Alice S Mims, Uma Borate, Eytan M Stein, Maria R Baer, Wendy Stock, Tibor Kovacsovics, William Blum, Martha L Arellano, Gary J Schiller, Reb...> ;Cancer. 2023 Apr 20
- Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy.Konstantinos Lontos, Anastasia Tsagianni, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou, Rafic Farah, Robert L Redner, Annie Im, Kathleen A Dorritie, Alison Sehgal, J...> ;Leukemia & Lymphoma. 2023 Mar 1
- A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML.Konstantinos Lontos, Anastasia Tsagianni, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou, Rafic Farah, Robert L Redner, Annie Im, Kathleen A Dorritie, Alison Sehgal, J...> ;Leukemia & Lymphoma. 2022 Dec 1
- Join now to see all
Grant Support
- Characterization Of A Novel Translocation Product In APLNational Cancer Institute2006–2009
- Calcitriol &Dexamethasone For Myelodysplastic SyndromesFood And Drug Administration2004
- Vitamin D And Dexamethasone In Myelodysplastic SyndromesNational Cancer Institute2002–2003
- Novel Translocation Product In APLNational Cancer Institute1995–1999
Hospital Affiliations
UPMC PresbyterianPittsburgh, Pennsylvania- UPMC Magee-Womens HospitalPittsburgh, Pennsylvania
- Shadyside CampusPittsburgh, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
